BDBM438951 (1R,5S,9r)-3-(bicyclo[1.1.1]pentan-1-yl)-9-(5-bromothiophen-2-yl)-3-azabicyclo[3.3.1]nonan-9-ol and (1R,5S,9s)-3-(bicyclo[1.1.1]pentan-1-yl)-9-(5-bromothiophen-2-yl)-3-azabicyclo[3.3.1]nonan-9-ol::US10604489, Compound 112::US11180455, Compound 112

SMILES COC1(C2CCCC1CN(C2)C12CC(C1)C2)c1ccc(s1)C(N)=O

InChI Key

Data  2 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 438951   

TargetMu-type opioid receptor(Human)
Alkermes

US Patent
LigandPNGBDBM438951((1R,5S,9r)-3-(bicyclo[1.1.1]pentan-1-yl)-9-(5-brom...)
Affinity DataKi:  3nMAssay Description:Membrane protein from CHO (Chinese Hamster Ovarian) cells that stably expressed one type of the cloned human opioid receptor were incubated with 12 d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Alkermes

US Patent
LigandPNGBDBM438951((1R,5S,9r)-3-(bicyclo[1.1.1]pentan-1-yl)-9-(5-brom...)
Affinity DataKi:  3nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent